Correction: Time to adjuvant chemotherapy after cytoreductive surgery and survival outcomes in epithelial ovarian cancer: a retrospective cohort study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Impact of Timing for Adjuvant Chemotherapy Following Cytoreductive Surgery on Survival in Epithelial Ovarian Cancer: A Retrospective Cohort Analysis

  • By

  • Kshitij Jamdade

  • Marios Katsanevakis

  • Tobechi Njoku

  • Nazifa Tasnim

  • Ambreen Yaseen

  • Oluwafemi Ogundiran

  • Sahana Subbiah

  • Mamuna Akram

  • Carmen Gan

  • Jafaru Abu

  • Santhanam Sundar

  • Srinivasan Madhusudan

  • Ketan Gajjar

  • September 3, 2026

Share

  • 1

    The article corrects the placement of Figure 1, which should be in the Results section, not the Methods and design section.

  • 2

    The final sentence of the Methods and design section regarding patient selection was removed due to an omitted Flow Diagram.

  • 3

    The study analyzed patients treated at Nottingham University Hospitals from January 2016 to December 2021.

  • 4

    Eligible patients had histologically confirmed epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.

  • 5

    The cohort included 145 patients, representing all eligible consecutive cases managed during the study period.

Original Source(s)

Related Content